Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole vs Fluticasone in Mild to Moderate Atopic Dermatitis
NCT07537751Completed
- Start
- Feb 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Randomised, double-blind trial of AN2728 ointment vehicle in atopic dermatitis (AD) (2 arms). Primary endpoint: Percentage improvement in objective SCORAD at 6 weeks. Started Feb 2024; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07537751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07537751.